Peripheral Nerve Stimulators Market Report 2026

The peripheral nerve stimulators market size has grown strongly in recent years. It will grow from $0.76 billion in 2025 to $0.83 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of non-invasive pain management solutions, high prevalence of chronic neuropathic pain, reliance on pharmaceutical interventions, low awareness of peripheral nerve stimulation therapies, fragmented distribution of neurostimulation devices.

The peripheral nerve stimulators market size is expected to see strong growth in the next few years. It will grow to $1.14 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in implantable and percutaneous stimulators, increasing adoption of transcutaneous electrical nerve stimulation (tens) units, expansion of ambulatory surgical centers and physiotherapy clinics, rising preference for rechargeable and disposable neurostimulation devices, growing awareness of non-pharmacological pain management solutions. Major trends in the forecast period include increasing adoption of ai-enabled pain management devices, rising use of cloud-based patient monitoring for neurostimulation, growing development of implantable and rechargeable neurostimulators, increasing integration of iot-enabled nerve stimulation systems, rising implementation of smart manufacturing for peripheral nerve stimulators.

The rising prevalence of neurological disorders is expected to drive the growth of the peripheral nerve stimulators market in the coming years. Neurological disorders are conditions that affect the brain, spinal cord, or peripheral nerves, resulting in functional, structural, or biochemical impairments. The increasing occurrence of these disorders is associated with factors such as aging populations, genetic susceptibility, environmental influences, lifestyle factors, and improved awareness and diagnosis. Peripheral nerve stimulators contribute to the management of neurological disorders by delivering targeted pain relief, improving motor function, and supporting nerve stimulation in affected areas. For instance, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit voluntary health organization, approximately 6.7 million Americans aged 65 years and older were living with Alzheimer’s dementia in 2023, with this number projected to reach 13.8 million by 2060. Therefore, the growing prevalence of neurological disorders is driving the growth of the peripheral nerve stimulators market.

Major companies operating in the peripheral nerve stimulators market are focusing on the development of advanced technologies such as ultra-miniaturized systems to improve patient comfort, enhance treatment effectiveness, and broaden therapeutic applications. Ultra-miniaturized systems are compact devices engineered with advanced technologies to deliver high performance while minimizing invasiveness. For example, in April 2023, NeuSpera Medical Inc., a US-based manufacturer of implantable medical devices, announced that it received clearance from the US Food and Drug Administration for its next-generation ultra-miniaturized NeuSpera system designed for chronic peripheral nerve pain management. This device delivers targeted electrical stimulation to peripheral nerves without the use of traditional leads, making it minimally invasive and reducing the risk of lead-related complications. Its small size allows for easier implantation with reduced tissue disruption, supporting faster recovery and offering long-term pain relief through direct stimulation of affected nerve pathways.

In November 2023, Boston Scientific Corporation, a US-based manufacturer of medical devices, acquired Relievant Medsystems Inc. for approximately $850 million. Through this acquisition, Boston Scientific expanded its chronic pain management portfolio by integrating Relievant Medsystems’ spinal nerve stimulation technologies. Relievant Medsystems Inc. is a US-based company specializing in the development and commercialization of minimally invasive therapies for chronic back pain, particularly treatments targeting vertebrogenic pain.

Major companies operating in the peripheral nerve stimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Nevro Corp., Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., STIM Systems, NeuroSigma Inc., Synapse Biomedical Inc., BioControl Medical, Cardionomic Inc., Aleva Neurotherapeutics SA, NeuroPace Inc., Nervonik Inc., NeuraStim Technologies Inc., NeuroPulse Systems Inc., NeuroStim Devices Inc., Peripheral NeuroSolutions Ltd, BlueWind Medical, PINS Medical, Neurimpulse, Cala Health Inc.

North America was the largest region in the peripheral nerve stimulators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral nerve stimulators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral nerve stimulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the peripheral nerve stimulators market by increasing costs of imported neurostimulation devices, stimulators, and electronic components, particularly in North America and Europe. This has slowed adoption in hospitals, physiotherapy centers, and clinics, while simultaneously encouraging local manufacturing, fostering innovation in cost-effective stimulators, and improving supply chain resilience across neurostimulation device segments.

The peripheral nerve stimulators market research report is one of a series of new reports that provides peripheral nerve stimulators market statistics, including peripheral nerve stimulators industry global market size, regional shares, competitors with a peripheral nerve stimulators market share, detailed peripheral nerve stimulators market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral nerve stimulators industry. This peripheral nerve stimulators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Peripheral nerve stimulators are medical devices designed to deliver controlled electrical impulses to peripheral nerves to help manage pain or enhance motor function. These devices are commonly used in the treatment of chronic pain conditions such as neuropathy and are also applied in the rehabilitation of patients with nerve injuries or neurological disorders by stimulating nerve activity.

The primary types of peripheral nerve stimulator products include transcutaneous, percutaneous, and implantable systems. Transcutaneous peripheral nerve stimulators, often referred to as TENS devices, are non-invasive systems that deliver electrical impulses through the skin to interrupt pain signals or stimulate the release of endorphins for pain relief. The range of devices includes stimulators, continuous peripheral nerve block catheters, pain pumps, and others. These products are available as disposable or rechargeable units and are utilized across various settings, including hospitals, physiotherapy centers, ambulatory surgical centers, clinics, and others.

The peripheral nerve stimulators market consists of sales of external peripheral nerve stimulators, implantable peripheral nerve stimulators, electrodes for nerve stimulation, and diagnostic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.